Modulating the Blood-Brain Barrier: A Comprehensive Review

被引:41
作者
Whelan, Rory [1 ,2 ]
Hargaden, Grainne C. [3 ]
Knox, Andrew J. S. [1 ,2 ]
机构
[1] Tech Univ Dublin, Sch Biol & Hlth Sci, Dublin D07 XT95, Ireland
[2] Technol Univ Dublin, Environm Sustainabil & Hlth Inst, Chem & Struct Biol, Dublin D07 H6K8, Ireland
[3] Technol Univ Dublin, Sch Chem & Pharmaceut Sci, Dublin D07 XT95, Ireland
关键词
blood-brain barrier (BBB); CNS drug delivery; tight junction (TJ); BBB permeability; BBB modulation; focused ultrasound; intra-arterial drug delivery; hyperosmolar agents; glioblastoma; alzheimers; GUIDED FOCUSED ULTRASOUND; ZONULA-OCCLUDENS TOXIN; POSITRON-EMISSION-TOMOGRAPHY; ACUTE INFLAMMATORY RESPONSE; TIGHT JUNCTION MODULATION; GLIOMA-BEARING RATS; IN-VITRO; CHEMOTHERAPEUTIC-AGENTS; DRUG-DELIVERY; GENE DELIVERY;
D O I
10.3390/pharmaceutics13111980
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The highly secure blood-brain barrier (BBB) restricts drug access to the brain, limiting the molecular toolkit for treating central nervous system (CNS) diseases to small, lipophilic drugs. Development of a safe and effective BBB modulator would revolutionise the treatment of CNS diseases and future drug development in the area. Naturally, the field has garnered a great deal of attention, leading to a vast and diverse range of BBB modulators. In this review, we summarise and compare the various classes of BBB modulators developed over the last five decades-their recent advancements, advantages and disadvantages, while providing some insight into their future as BBB modulators.
引用
收藏
页数:54
相关论文
共 267 条
[1]   Inflammatory mediators and modulation of blood-brain barrier permeability [J].
Abbott, NJ .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2000, 20 (02) :131-147
[2]   First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound [J].
Abrahao, Agessandro ;
Meng, Ying ;
Llinas, Maheleth ;
Huang, Yuexi ;
Hamani, Clement ;
Mainprize, Todd ;
Aubert, Isabelle ;
Heyn, Chinthaka ;
Black, Sandra E. ;
Hynynen, Kullervo ;
Lipsman, Nir ;
Zinman, Lorne .
NATURE COMMUNICATIONS, 2019, 10 (1)
[3]   Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival [J].
Alkins, Ryan ;
Burgess, Alison ;
Kerbel, Robert ;
Wels, Winfried S. ;
Hynynen, Kullervo .
NEURO-ONCOLOGY, 2016, 18 (07) :974-981
[4]   Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors [J].
Alkins, Ryan ;
Burgess, Alison ;
Ganguly, Milan ;
Francia, Giulio ;
Kerbel, Robert ;
Wels, Winfried S. ;
Hynynen, Kullervo .
CANCER RESEARCH, 2013, 73 (06) :1892-1899
[5]   Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening [J].
Alonso, Angelika ;
Reinz, Eileen ;
Leuchs, Barbara ;
Kleinschmidt, Juergen ;
Fatar, Marc ;
Geers, Bart ;
Lentacker, Ine ;
Hennerici, Michael G. ;
de Smedt, Stefaan C. ;
Meairs, Stephen .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 :e73
[6]   Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients [J].
Annunziata, Pasquale ;
Cioni, Chiara ;
Masi, Gianni ;
Tassi, Maristella ;
Marotta, Giuseppe ;
Severi, Sauro .
SCIENTIFIC REPORTS, 2018, 8
[7]   Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises [J].
Armulik, Annika ;
Genove, Guillem ;
Betsholtz, Christer .
DEVELOPMENTAL CELL, 2011, 21 (02) :193-215
[8]   Drug delivery system of therapeutic oligonucleotides [J].
Asami, Yutaro ;
Yoshioka, Kotaro ;
Nishina, Kazutaka ;
Nagata, Tetsuya ;
Yokota, Takanori .
DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (05) :256-262
[9]  
Atkinson F., 2002, Current Medicinal Chemistry - Central Nervous System Agents, V2, P229, DOI 10.2174/1568015023358058
[10]   Glial and neuronal control of brain blood flow [J].
Attwell, David ;
Buchan, Alastair M. ;
Charpak, Serge ;
Lauritzen, Martin ;
MacVicar, Brian A. ;
Newman, Eric A. .
NATURE, 2010, 468 (7321) :232-243